
Actionable equity research, rigorous valuation models, and a transparent tracking portfolio.
| Platform | Pricing | Freemium | Publishes | Daily | |
|---|---|---|---|---|---|
| Issues | 66 | Founded | a year ago | Last Issue | 6 days ago |
| Active | |||||

Celsius didn't just disrupt the Monster & Red Bull duopoly—they absorbed the competition. Inside the PepsiCo engine and the definitive $CELH valuation.
What began in the early 2000s as a niche, science-backed “fat-burning” supplement strug...
Brazil was just the warmup. Inside the Mexico commercial unlock, the U.S. expansion strategy, and the math behind the 26% CAGR opportunity.
For the better part of a decade, traditional banking institutions across Latin America—characterize...
Discover why Wall Street loves this financial tollbooth. Unpacking FICO's 85% margins, ruthless "cannibal" share buybacks, and 5-year valuation.
You probably know your FICO score. If you’ve ever applied for a mortgage, an auto loan, or a c...
Over the past decade, the United States dollar has exhibited remarkable strength, often defying expectations and cementing its status as the world’s premier reserve currency. This...
Is the hype around GTA 6 already priced into Take-Two Interactive ($TTWO), or is the stock still a coiled spring? In Episode 8 of Talkin’ Stocks, we break down Take-Two’s financial shift toward recurring revenue and look under the hood at t...
Subscribers, engagement, traffic and sponsorship for CompoundingAlpha.
| Subscribers | Engagement | 77 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
The writers behind this newsletter.
Fundamental equity research driven by rigorous hours of digging through SEC filings and DCF modeling. 32.8% CAGR since '22.
Tracking biotech & Banking acquisition targets Featuring acquisition targets with detailed analysis M&A probability signals and catalysts Valuation insight and deal timing estimates Big pharma strategy patterns "NOT Pro Advice"
You can find recent issues that have been published by CompoundingAlpha on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to CompoundingAlpha, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch CompoundingAlpha as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact CompoundingAlpha using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like CompoundingAlpha. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.